Td Private Client Wealth LLC Iovance Biotherapeutics, Inc. Transaction History

Td Private Client Wealth LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Aug 16, 2024	SELL	$12.38 - $19.1 $433 - $668	-35 Closed	0 $0
Q4 2021 Aug 16, 2024	SELL	$16.55 - $27.63 $1,588 - $2,652	-96 Reduced 73.28%	35 $668,000
Q3 2021 Aug 16, 2024	BUY	$20.35 - $26.63 $2,665 - $3,488	131 New	131 $3.23 Million
Q2 2021 Aug 16, 2024	BUY	$16.33 - $33.07 $783 - $1,587	48 Added 81.36%	107 $2.78 Million
Q4 2020 Aug 16, 2024	BUY	$28.04 - $50.26 $701 - $1,256	25 Added 73.53%	59 $2.74 Million
Q4 2019 Aug 16, 2024	BUY	$17.95 - $29.41 $610 - $999	34 New	34 $941,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.3B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Td Private Client Wealth LLC with notifications on news.